Thus, our study reveals a possible phosphorylation-dependent regulatory mechanism involved in regulation of PrLZ stability dictated by SPOP-induced degradation, potentially opening new therapeutic avenues for PCa treatment. This evidence concerns the gene TPD52 and posterior cortical atrophy.